Inhaled corticosteroids (ICS) and bone mineral density (BMD) - a follow-up study. The bronchial obstruction in Nord-Trøndelag study (BONT) Source: Eur Respir J 2004; 24: Suppl. 48, 601s Year: 2004
The influence of inhalation thechnics at the long application of high dose inhaled corticosteroids on the mineral bone density (MBD) in children Source: Eur Respir J 2004; 24: Suppl. 48, 133s Year: 2004
The likelihood of low bone mineral density (BMD) in male patients with chronic obstructive pulmonary disease (COPD) in age 40-70 years Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care Year: 2012
Bone mineral density (BMD) in male patients with chronic obstructive pulmonary disease (COPD) in age 40-70 years Source: Annual Congress 2011 - Morphological and functional imaging in obstructive airway disease Year: 2011
Effects of long term used inhaled corticosteroids on growth and bone mineral density in asthmatic children Source: Eur Respir J 2005; 26: Suppl. 49, 159s Year: 2005
A comparison of bone mineral density in elderly patients with COPD and bronchial asthma Source: Annual Congress 2007 - COPD and comorbidity Year: 2007
Long-term effects of corticosteroid use on bone mineral density in asthmatic children Source: Breathe 2008; 5: 70-71 Year: 2008
The influence of high dose beclomethasone dipropionate (BDP) on bone density in perimenopausal women with bronchial asthma (BA) Source: Eur Respir J 2004; 24: Suppl. 48, 508s Year: 2004
Bone mineral density and inhaled budesonide – a systematic review of long-term treatment in children and adults Source: Eur Respir J 2005; 26: Suppl. 49, 276s Year: 2005
Severe asthma and high doses of corticosteroid adversely impact trabecular bone score more than bone mineral density Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018
Bone mineral density reduction and long term use of inhaled corticosteroids Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care Year: 2008
Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler(R) Source: Eur Respir J 2002; 19: 1058-1063 Year: 2002
Bone mineral density (BMD) measuring in patients suffering from pulmonary disease under glucocorticoid treatment - fashioned trend or necessity? Source: Eur Respir J 2005; 26: Suppl. 49, 526s Year: 2005
Is there a risk of bone fracture in asthmatic children treated with inhaled ICS? Source: ISSN=ISSN 1810-6838, ISBN=, page=244 Year: 2005
Apparent high prevalence of reduced bone mineral density in an adolescent asthma clinic Source: Eur Respir J 2004; 24: Suppl. 48, 614s Year: 2004
Inhaled corticosteroids and bone mineral density in children: A prospective 12-year follow-up study after early-life wheezing Source: Annual Congress 2012 - Treating childhood asthma Year: 2012
Lack of association between inhaled corticosteroids and bone density in postmenopausal women Source: Eur Respir J 2001; 18: Suppl. 33, 442s Year: 2001
The evaluation of bone density in the patients with bronchial asthma treated with glucocorticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 51s Year: 2002
Relationship between structural bone changes assessed by ultrasound bone densitometry (UBD) and growth hormone (GH) during chronic treatment with inhaled corticosteroids (ICS) in asthmatic patients Source: Eur Respir J 2003; 22: Suppl. 45, 419s Year: 2003
Bone mineral density in patients with COPD depending on pulmonary function parameters Source: Annual Congress 2011 - COPD mechanisms Year: 2011